Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 4.850
+0.500 (11.49%)
Nov 5, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,514 | 1,595 | 1,859 | 2,299 | 2,187 | 2,971 |
Revenue Growth | 2.90% | -14.16% | -19.16% | 5.13% | -26.38% | -3.30% |
Gross Profit Gross Profit Growth | 399.11 | 422.89 | 407.61 | 743.33 | 533.38 | 741.4 |
Operating Income Operating Income Growth | -16.89 | -102.06 | -233.92 | 49.67 | -175.35 | -22.39 |
Net Income Net Income Growth | -1,448 | -1,392 | -858.56 | -388.96 | -530.06 | -688.47 |
Earnings Per Share EPS Growth | -2.18 | -2.11 | -1.30 | -0.59 | -0.80 | -1.04 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Distribution Pharmaceutical Distribution Growth | 75.61 | 252.4 | 360.36 | 588.12 | 868.86 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 430.57 | 302.7 | 825.29 | 384.52 | 475.2 |
Others Others Growth | 357.75 | 347.37 | 351.47 | 273.85 | 170.5 |
Offset of Business Segment Offset of Business Segment Growth | -278.26 | - | - | - | - |
Medical Instruments Medical Instruments Growth | 19 | 20.09 | 17.42 | 16.2 | 14.8 |
Chinese Herbal Medicines Chinese Herbal Medicines Growth | 990.74 | 936.1 | 744.75 | 924.37 | 1,209 |
Total Total Growth | 1,595 | 1,859 | 2,299 | 2,187 | 2,971 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 165.45 | 254.57 | 144.74 | 149.32 | 166.63 | 367.17 |
Total Debt Total Debt Growth | 1,387 | 1,467 | 2,243 | 2,433 | 2,458 | 3,448 |
Net Cash (Debt) Net Cash Growth | -1,222 | -1,212 | -2,098 | -2,284 | -2,291 | -3,081 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.84 | -1.84 | -3.18 | -3.46 | -3.46 | -4.65 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 53.24 | 139.63 | 18.17 | 263.44 | 227.38 | 257.56 |
Capital Expenditures CapEx Growth | -27.06 | -21.51 | -35.24 | -56.03 | -367.27 | -562.74 |
Free Cash Flow Free Cash Flow Growth | 26.18 | 118.12 | -17.07 | 207.41 | -139.89 | -305.18 |
Free Cash Flow Growth | -57.06% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 26.37% | 26.51% | 21.93% | 32.33% | 24.39% | 24.96% |
Operating Margin | -1.12% | -6.40% | -12.58% | 2.16% | -8.02% | -0.75% |
Pretax Margin | -90.36% | -83.79% | -45.31% | -16.92% | -23.40% | -21.40% |
Profit Margin | -95.67% | -87.26% | -46.19% | -16.92% | -24.24% | -23.18% |
FCF Margin | 1.73% | 7.40% | -0.92% | 9.02% | -6.40% | -10.27% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Forward PE | - | 11.93 | 11.93 | 11.93 | 11.93 | 11.93 |
P/FCF Ratio | 122.49 | 50.95 | - | 16.42 | - | - |
PS Ratio | 2.12 | 3.77 | 3.48 | 1.48 | 1.81 | 1.77 |